“This trial provides, for the first time, evidence that CBD taken at a relatively high dose can reduce self-reported pain intensity in individuals with chronic neuropathic pain.”
Region: Australia
“Clinically meaningful pain relief – defined as a ≥ 30 percent reduction in [patients’] average daily pain scores – was achieved by 70 percent of the treatment group.”
Researchers identified no changes in patients’ enzyme levels in a manner that would be indicative of liver damage.
THC-positive subjects exhibit a significantly lower prevalence of metabolic syndrome, even after researchers adjust for potential confounders.
Researchers concluded, “These findings indicate that the introduction of cannabinoids can produce useful reductions in opioid consumption in real-world settings.”
Consistent with prior studies, patients drove at slower speeds and increased the distance between their vehicle and the vehicles in front of them following THC dosing.
“This study uniquely contributes to the evidence on the benefits and safety of medicinal cannabis in adolescents with Tourette syndrome,” investigators concluded.
Rett Syndrome is a rare genetic disorder associated with developmental delays, seizures, loss of speech and motor coordination, and involuntary/repetitive movements, among other symptoms.